FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to infectious diseases and can be used for emergency post-exposure prevention of tick-borne encephalitis. For this purpose after removing the tick in the immediate vicinity of the suction site, a subcutaneous injection of human immunoglobulin against tick-borne encephalitis containing antibodies that neutralize TBEV is produced in a titer of 1:80 or more at a dose of 1.0 ml.
EFFECT: invention ensures the achievement of a high concentration of virus-neutralizing antibodies directly in tissues infected with tick-borne encephalitis virus.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF EMERGENCY PREVENTION OF TICK - BORNE ENCEPHALITIS | 2018 |
|
RU2681546C1 |
PHARMACEUTICAL COMPOSITION FOR PASSIVE RABIES IMMUNIZATION, PHARMACEUTICAL KIT, PHARMACEUTICAL KIT APPLICATION METHOD | 2016 |
|
RU2661028C2 |
METHOD OF TREATING TICK-BORNE ENCEPHALITIS | 2011 |
|
RU2473364C2 |
METHOD OF TREATING FOCAL FORM OF MIXED ENCEPHALITIS-BORRELIOSIS INFECTION IN ACUTE PERIOD | 2015 |
|
RU2602740C1 |
METHOD FOR PROPHYLAXIS OF TICK-BORNE ENCEPHALITIS IN CHILDREN | 2005 |
|
RU2281784C1 |
mRNA-BASED IMMUNOBIOLOGICAL AGENT FOR PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS | 2024 |
|
RU2823754C1 |
AGENT "IODANTIPIRIN" FOR PROPHYLAXIS AND TREATMENT OF PATIENTS WITH TICK-BORNE ENCEPHALITIS | 1997 |
|
RU2141826C1 |
METHOD FOR PROPHYLAXIS OF TICK-BORNE ENCEPHALITIS | 2004 |
|
RU2261105C1 |
IMMUNOBIOLOGICAL AGENT FOR THE PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS BASED ON A RECOMBINANT VIRUS OF THE GENUS FLAVIVIRUS | 2022 |
|
RU2795800C1 |
RECOMBINANT PLASMID pHis6-flagG-protE, WHICH PROVIDES SYNTHESIS OF A RECOMBINANT CHIMERIC PROTEIN, INCLUDING EPITOPES OF GLYCOPROTEIN E OF TICK-BORNE ENCEPHALITIS VIRUS AND FLAGELLIN G SALMONELLA TYPHII AND USED AS A BASE FOR VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2018 |
|
RU2702716C2 |
Authors
Dates
2019-03-20—Published
2017-09-07—Filed